| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 2117-2120, Copyright © 1996 by Endocrine Society
ARTICLES |
WM Bennet, ZL Wang, PM Jones, RM Wang, RF James, NJ London, MA Ghatei and SR Bloom
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.
Neuropeptide Y (NPY) has been shown to decrease insulin secretion from rodent islets. NPY messenger ribonucleic acid (mRNA) has been demonstrated in rat and mouse pancreatic islets. We, therefore, examined human islets for the presence of NPY-encoding mRNA and NPY- like immunoreactivity. Human pancreatic islets were obtained from cadaveric organ donors, using collagenase digestion and purification on BSA density gradients. Northern blot analysis, employing a human NPY riboprobe, revealed specific NPY-encoding mRNA in the islet. Compared to the islet, NPY message abundance was 9-fold higher in the caudate nucleus and 2.4-fold higher in the temporal lobe, but it was 75% lower in the adrenal gland. NPY-like immunoreactivity was present at 2.4 +/- 0.3 fmol/microgram protein in acid-ethanol extracts from the islets. On fast protein liquid chromatography with a reverse phase column, the majority of NPY-like immunoreactivity eluted as a peak with a retention time identical to that of porcine NPY standard. Added NPY (100 nmol/L) decreased (P = 0.001) glucose-stimulated (8 mmol/L) insulin release from the human islets by 45% in a perfusion system. Therefore, human islets synthesize substantial amounts of NPY, which could act as an intra-islet paracrine regulator.
This article has been cited by other articles:
 |
|
 |
|
  Y. Imai, H. R. Patel, E. J. Hawkins, N. M. Doliba, F. M. Matschinsky, and R. S. Ahima Insulin Secretion Is Increased in Pancreatic Islets of Neuropeptide Y-Deficient Mice Endocrinology, December 1, 2007; 148(12): 5716 - 5723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ma, S. Nordman, A. Mollsten, H. Falhammar, K. Brismar, G. Dahlquist, S. Efendic, and H. F Gu Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations Eur. J. Endocrinol., November 1, 2007; 157(5): 641 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Jaakkola, T. Kuusela, T. Jartti, U. Pesonen, M. Koulu, T. Vahlberg, and J. Kallio The Leu7Pro Polymorphism of PreproNPY Is Associated with Decreased Insulin Secretion, Delayed Ghrelin Suppression, and Increased Cardiovascular Responsiveness to Norepinephrine during Oral Glucose Tolerance Test J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3646 - 3652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kallio, U. Pesonen, U. Jaakkola, M. K. Karvonen, H. Helenius, and M. Koulu Changes in Diurnal Sympathoadrenal Balance and Pituitary Hormone Secretion in Subjects with Leu7Pro Polymorphism in the Prepro-Neuropeptide Y J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3278 - 3283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kushi, H. Sasai, H. Koizumi, N. Takeda, M. Yokoyama, and M. Nakamura Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice PNAS, December 22, 1998; 95(26): 15659 - 15664. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
